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Abstract 
Background: Bacillus amyloliquefaciens B10‑127 exhibited an excellent ability for industrial‑scale microbial fermenta‑
tion of 2,3‑butanediol (2,3‑BD) from biodiesel‑derived glycerol. However, the accumulation of by‑products (acetoin, 
acetoin, lactate and succinate) and the 2,3‑BD yield remains prohibitively low for commercial production.
Results: Several strategies were developed to manipulate the carbon flux to 2,3‑BD branch in a designed B. 
amyloliquefaciens. Firstly, extra copies of NADH/NAD+ regeneration system were introduced into B. amyloliquefaciens 
by co‑overproduction of glycerol dehydrogenase and acetoin reductase, which resulting in improvement of 2,3‑BD 
production and suppression of by‑products accumulation. Subsequently, the transcriptional regulator ALsR under the 
control of a moderate promoter PbdhA was introduced into B. amyloliquefaciens, which increased carbon flux to 2,3‑BD 
branch. Finally, a three‑stage dissolved oxygen control strategy were proposed based on analysis of the characteristic 
of 2,3‑BD fermentation, and a two‑stage pH control strategy were proposed based on different pH preferences of 
ACR for reduction and oxidation. Following these strategies, a high titer (102.3 g/L), yield (0.44 g/g), and productivity 
(1.16 g/L/h) of 2,3‑BD were achieved.
Conclusions: To our knowledge, this is the highest reported 2,3‑BD production using biodiesel‑derived glycerol as 
substrate, and this designed B. amyloliquefaciens should be an excellent candidate for producing 2,3‑BD on an indus‑
trial scale.
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Background
2,3-Butanediol (2,3-BD) has potential applications in 
the manufacture of foods, pharmaceuticals fumigants, 
printing inks, moistening and softening agents, plasticiz-
ers [1]. Interest in microbial production of 2,3-BD has 
increased significantly because 2,3-BD has a wide range 
of industrial applications, and microbial production will 
alleviate the dependence on oil supply for the production 
of platform chemicals [2, 3].
To date, many studies on 2,3-BD production have 
focused on sugar fermentation. Despite the high-effective 
productivities that have been achieved via the conversion 
of glucose [4], the relatively high cost of conventional 
sugar substrates is still viewed as a major factor during 
2,3-BD fermentation. Therefore, 2,3-BD production using 
cheaper alternative biomass-derived substrates under 
proper conditions is of high priority [2]. Biodiesel pro-
duction from plant oils and animal fats reportedly gen-
erate large quantities of by-product waste glycerol [5]. 
For example, approximately 10 % of the biodiesel weight 
produced is waste glycerol [6]. In some European coun-
tries, the production of glycerol has increased signifi-
cantly due to biodiesel uptake. However, those biodiesel 
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companies have severe problems getting rid of excess 
glycerol and disposal is quite expensive. The collapse of 
glycerol prices causes major problems to these compa-
nies [7]. Since glycerol can be used as a carbon source in 
industrial microbiology, this by-product adds value to the 
productive chain of the biodiesel industry, contributing 
to their competitiveness [6]. Raw non-purified glycerol is 
an economical substitute for pure glycerol as a fermen-
tation substrate. Therefore, converting the vast amounts 
of glycerol into cost-effective commercial products is an 
industrial priority. Some researchers have reported that 
Klebsiella strains can catalyze pure glycerol into 2,3-BD, 
but these reactions generate large quantities of 1,3-PD [8, 
9]. Importantly, because Klebsiella pneumoniae is a path-
ogenic microorganism, it does not conform to the safety 
regulations of industrial-scale fermentation [3]. Metso-
viti et al. [10] obtained a 2,3-BD concentration of 22 g/l 
and with a relatively high conversion yield on glycerol 
consumed of 0.40 g/g with a newly isolated Enterobacter 
aerogenes FMCC-10; however, the efficiency of the pro-
duction was still much too low for an economic process.
Previously, we reported that B. amyloliquefaciens read-
ily produces 2,3-BD from biodiesel-derived glycerol in 
the presence of beet molasses as a co-substrate [11]. In 
fed-batch fermentation, 2,3-BD production (83.3  g/L) 
from waste glycerol reached the highest level reported 
to date, but fermentation was accompanied by undesir-
ably large production of acetoin, lactate, acetate, and 
succinate. However, both raw glycerol and molasses are 
easily available by-products from plant (mostly) bio-
mass conversion, and they represent abundant renewable 
feed stocks and furthermore, they need no pretreatment 
before fermentation processes. So microbial production 
of 2,3-BD from these raw materials is potentially eco-
nomically feasible if bacterial strain used for this pur-
pose produces at least 100 g 2,3-BD per L (the recovery 
of 2,3-BD from culture broth is troublesome and usually 
energy-consuming distillation is necessary). However, 
neither process conditions have been optimized (it was 
just comparison of the effect of pure glucose or sucrose, 
or molasses on 2,3-BD biosynthesis yield) nor the strain 
was improved by genetic engineering methods.
The 2,3-BD pathway has been studied in various bacte-
ria [12]. As shown in Scheme 1, assimilation of glycerol 
to produce 2,3-BD is also an oxido-reduction-associated 
process. In the oxidative pathway, the NAD+-dependent 
glycerol dehydrogenase (GDH) oxidizes glycerol to dihy-
droxyacetone, which is subsequently oxidized to pyru-
vate. Acetolactate synthase (ALS) catalyzes the in  vivo 
coupling of two pyruvate molecules to form acetolactate, 
which is then decarboxylated to acetoin by acetolactate 
decarboxylase (ALDC). Finally, acetoin is reduced to 2,3-
BD by an NADH-dependent acetoin reductase (ACR) 
[13]. Bacterial strains may accumulate acetoin for sev-
eral reasons. One factor that limits acetoin degradation 
is low levels of ACR, assumed as the rate-limiting factor 
in the conversion of acetoin into 2,3-BD. Alternatively, 
low levels of NADH may limit the ACR reaction, since 
Scheme 1 The strategy for designed B. amyloliquefaciens to manipulate the carbon flux to 2,3‑BD branch. To make the 2,3‑BD branch gains a 
competitive advantage over the end products of pyruvate‑deriving pathways (such as acetic acid, lactic acid and succinic acid), several strategies 
were developed to manipulate the carbon flux to 2,3‑BD branch in a designed B. amyloliquefaciens. Firstly, extra copies of NADH/NAD+ regeneration 
system were introduced into B. amyloliquefaciens by co‑overproduction of glycerol dehydrogenase and acetoin reductase. Subsequently, the tran‑
scriptional regulator ALsR under the control of a moderate promoter PbdhA was introduced into B. amyloliquefaciens. Finally, a three‑stage dissolved 
oxygen control strategy were proposed based on analysis of the characteristic of 2,3‑BD fermentation, and a two‑stage pH control strategy were 
proposed based on different pH preferences of ACR for reduction and oxidation
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this coenzyme is preferentially used in 2,3-BD synthe-
sis. However, some other by-products are also produced 
by B. amyloliquefaciens, such as succinate, lactate, and 
acetate, which negatively regulate the 2,3-BD yield and 
increase the costs of downstream separation and purifi-
cation. Furthermore, large-scale microbial 2,3-BD pro-
duction requires efficient and economical fermentation 
processes. Thus, in this work, we focused on improving 
strains to produce 2,3-BD with high yield, using low price 
substrates (raw glycerol and molasses) to lower the cost 
of feedstock, and optimizing the operation mode to make 
the process more efficient (Scheme 1).
Results and discussion
Over‑production of glycerol dehydrogenase and its effects 
on 2,3‑BD production
Glycerol dehydrogenase (GDH) is an important polyol 
dehydrogenase for glycerol metabolism in diverse micro-
organisms, and for value-added utilization of glycerol in 
the industry that catalyzes the dehydrogenation of glyc-
erol to dihydroxyacetone. This reaction is coupled to the 
reduction of oxidized NAD+ to NADH. So, over-produc-
tion of glycerol dehydrogenase could increase not only 
the dehydrogenation of glycerol but also the level of avail-
able NADH.
In the genome sequence of K. pneumoniae ATCC 
25955, there are two GDHs (DhaD and GldA) [14]. So, 
the two enzymes were separately introduced into B. 
amyloliquefaciens, and generated recombinant strains 
DH and GL, respectively. As shown in Table 1, the spe-
cific activities of GDH in strains DH and GL were sepa-
rately 4.76 and 3.02 folds higher than in the parental 
strain. Also, the highest 2,3-BD concentration were 
increased by 10.7  % with strain DH and 6.35  % with 
strain GL, which suggested that overproduction of DhaD 
was more efficient for 2,3-BD production. Wang et  al. 
[14] found that DhaD is highly induced by glycerol, and 
apart from catalyzing the dehydrogenation of glycerol 
to dihydroxyacetone, it also could catalyze the reduc-
tion of acetoin to 2,3-BD in the presence of NADH. In 
other words, DhaD plays a dual role in glycerol metab-
olism and 2,3-butanediol formation. Therefore, DhaD 
over-eproduction might enhance 2,3-BD production by 
increasing not only the level of available NADH but also 
catalytic activity of 2,3-BD formation.
Introduction of extra copies of DhaD/ACR enzymes into B. 
amyloliquefaciens and their effects on 2,3‑BD production
The NAD+-dependent DhaD oxidizes glycerol to dihy-
droxyacetone, with concomitant reduction of NAD+ to 
NADH. In contrast, the NADH-dependent ACR reduces 
acetoin to 2,3-BD, with concomitant oxidation of NADH 
to NAD+. So, co-overproduction of DhaD and ACR may 
enhance 2,3-BD production [15]. Inspired by this idea, 
the dhaD gene harbored in pMA5-acr was overexpressed 
in the strain GA. The plasmid genetic rate remained 
about 95  %, indicating that the pMA5-acr-HapII-dhaD 
was stably expressed in the strain GA. The specific activi-
ties of GDH (0.67 ± 0.06 U/mg) and ACR (0.58 ± 0.05 U/
mg) in the strain GA were 4.58-fold and 3.66-fold higher 
than in the strain B10-127, respectively.
The effects co-overexpression of dhaD and acr on cell 
growth and 2,3-BD production were also investigated. As 
shown in Fig. 1a, the strain GA grew at a slightly lower 
rate compared to that of the parent strain (B10-127), sug-
gesting that cell growth was slightly inhibited by the over-
production of DhaD/ACR. As shown in Fig. 1b, the strain 
GA consumes glycerol more slowly than the parental 
strain during the exponential growth phase. However, the 
fermentation rate of the engineered strain GA remarkably 
increased in the stationary phase, with consequent reduc-
tion in fermentation time. Furthermore, co-overproduc-
tion of DhaD and ACR in B. amyloliquefaciens increased 
the highest 2,3-BD titer by 13.6 %, while decreasing the 
acetoin concentration by 64.6 % (see Fig. 1c, d). In addi-
tion, other by-products production, such as acetate, lac-
tate and succinate, were also suppressed. However, in 
both parental and engineered strains, the intracellular 
NADH and NAD+ concentration had no difference dur-
ing the glycerol fermentation (data not shown), possibly 
because introducing extra copies of DhaD/ACR enzymes 
into B. amyloliquefaciens accelerated the NADH/NAD+ 
regeneration rate without influencing the NAD+/NADH 
levels. Two reasons may account for this phenomenon. 
Table 1 Effect of over-production of GDH on 2,3-BD production in B. amyloliquefaciens
CGly glycerol consumption, CSuc sucrose consumption, GDH glycerol dehydrogenase
Batch fermentation was carried out at 37 °C in 250-mL flasks [95 g/l co-substrate; molasses to crude glycerol ratio 1.5:8 (w/w)] at 37 °C and shaking speed 180 rpm
Strains CGly (g/L) CSuc (g/L) Specific activity 
of GDH (U/mg)
2,3‑BD (g/L) Acetoin (g/L) Lactate (g/L) Acetate (g/L) Succinate (g/L) DCW (g/L)
B10‑127 80 ± 2 10 ± 1 0.12 ± 0.01 31.3 ± 1.03 8.56 ± 0.36 2.12 ± 0.10 1.11 ± 0.06 3.65 ± 0.15 9.21 ± 0.26
DH 80 ± 2 10 ± 1 0.69 ± 0.06 34.6 ± 1.12 4.87 ± 0.21 2.46 ± 0.12 1.02 ± 0.05 3.96 ± 0.17 9.12 ± 0.21
GL 80 ± 2 10 ± 1 0.48 ± 0.04 33.3 ± 1.15 6.65 ± 0.29 2.38 ± 0.12 1.04 ± 0.06 3.81 ± 0.16 9.16 ± 0.22
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First, over-production of NAD+-dependent DhaD 
increased the rate of glycerol consumption and NADH 
level. Second, in the glycerol metabolism, the 2,3-BD 
branch is primarily responsible for oxidizing NADH, and 
when NADH-dependent ACR is overproduced, the 2,3-
BD branch gains a competitive advantage over the end 
products of pyruvate-deriving pathways (such as lactic 
acid and succinic acid), through the enhanced availability 
of NADH. So, when extra copies of DhaD/ACR enzymes 
were introduced into B. amyloliquefaciens, it was found 
that overexpressing the NADH/NAD+ regeneration sys-
tem effectively improved 2,3-BD production and inhib-
ited by-products accumulation.
Manipulating the carbon flux from pyruvic acid 
to 2,3‑butanediol branch by moderate expression of the 
transcriptional regulator ALsR
There are three key enzymes involved in 2,3-BD branch, 
i.e. α-acetolactate synthase (ALS), α-acetolactate decar-
boxylase (ALDC), and acetoin reductase (ACR). To make 
the 2,3-BD branch gains a competitive advantage over 
the end products of pyruvate-deriving pathways (such as 
acetic acid, lactic acid and succinic acid), in our pre-test, 
we attempted to overexpress ALS and ALDC to enhance 
acetoin production. And we succeeded in increasing the 
activity of these enzymes by more than 50-fold, however, 
2,3-BD production was not significantly enhanced and 
cell growth was markedly inhibited. ALS and ALDC are 
encoded by the alsSD operon in B. subtilis [16]. It has 
been reported that the transcriptional regulator ALsR is 
essential for the expression of alsSD [17] and that the dis-
ruption of alsR prevents the transcription of alsSD [16].
The recombinant plasmids pMA5-HpaII-alsR and 
pMA5-PbdhA-alsR constructed using the strong HpaII 
and moderate PbdhA promoters to express ALsR, respec-
tively [18]. In the preliminary study, to improve the car-
bon flux to 2,3-BD branch, alsR under the control of two 
different promoters (HpaII and PbdhA) were cloned into B. 
amyloliquefaciens B10-127, respectively. 2,3-BD produc-
tion was improved by regulating ALsR expression using 
either of the two promoters. However, although ALsR 
expression was higher under the control of the stronger 
promoter (HpaII) than the moderate promoter (PbdhA), 
moderate enhancement of ALsR expression was more 
benefic to improve 2,3-BD production. Compared with 
the parent strain, 2,3-BD concentration increased by 
Fig. 1 Time profiles of 2,3‑BD fermentation (a cell growth; b glycerol consumption; c 2,3‑BD production; d acetoin formation). Batch fermentation 
was carried out at 37 °C in a 5‑L bioreactor containing 2.5‑L initial medium [95 g/L co‑substrate; molasses to crude glycerol ratio 1.5:8 (w/w)] at 
37 °C, agitation speed 350 rpm, and airflow rate 0.66 vvm
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9.2 % and 15.4 % under the control of and PbdhA, respec-
tively. Furthermore, the rates of cell growth and glucose 
consumption under the control of HpaII were lower than 
under the control of PbdhA. Zhang et al. [18] also reported 
that moderate enhancement of ALsR expression was 
more efficient for acetoin (precursor of 2,3-BD) produc-
tion than strong over-expression of ALsR.
So, we selected the moderate PbdhA promoter to express 
ALsR in B. amyloliquefaciens GA. The plasmid genetic 
rate of the resulting GAR recombinant remained stable at 
about 95  %, indicating that the pMA5-dhaD-HapII-acr-
PbdhA-alsR was stably expressed in the GAR strain. The 
specific activities of ALS (0.82 ± 0.07 U/mg) and ALDC 
(0.25 ± 0.03 U/mg) in the GAR strain were respectively 
1.02-fold and 1.76-fold higher than in the GA strain.
As shown in Fig. 1a, the GA strain had a faster growth 
rate than the recombinant strains, suggesting that ALsR 
expression inhibited cell growth. All of the glycerol 
(80 g/L) was consumed within 44 h (Fig. 1b), and strain 
GAR produced approximately 38.8 g/L 2,3-BD (Fig. 1c), 
respectively. And main by-products production, such as 
acetoin, acetate, lactate and succinate, were further sup-
pressed (Table  2). The main reason might be that the 
2,3-BD branch gains a competitive advantage over the 
end products of pyruvate-deriving pathways. Thus, an 
excellent 2,3-BD producer from glycerol was redesigned 
through introducing extra copies of DhaD/ACR enzymes 
and improving catalytic activities of enzymes involved in 
2,3-BD synthetic branch.
Metabolic flux redistributions
In the aerobic glycerol metabolism of B. amylolique-
faciens, 2,3-BD plays a major role in oxidizing NADH. 
To secure NADH and C, it must compete with other 
end products of pyruvate-deriving pathways. Thus, 
this study characterized the metabolic flexibilities of B. 
amyloliquefaciens in response to over-expression of the 
dhaD, acr and alsR genes. For this purpose, the concen-
trations of major metabolites of both strains (B10-127, 
GAR) were determined (titers of 2,3-BD, acetoin, succi-
nate, lactate and acetic acid). As shown in Table 2, com-
pared with the parent strain, the molar yield of 2,3-BD 
was higher (24.1  %), and the molar yields of unwanted 
by-products were significantly lower in the mutant 
strain (64.9, 55.4, 58.3 and 36.9  % for acetoin, lactate, 
succinate and acetate, respectively). This observation 
suggests that moderate enhancement of ALsR and co-
overproduction of DhaD, ACR in strain B10-127 make 
the 2,3-BD branch gain a competitive advantage over the 
end products of pyruvate-deriving pathways. And this 
result also indicates that glycerol fluxes are redistributed 
in B. amyloliquefaciens.
Manipulating the carbon flux from acetoin 
to 2,3‑butanediol by using a three‑stage oxygen control 
strategy
Oxygen supply is one of the most important variables in 
the 2,3-BD fermentation [2, 3]. Jansen et  al. [19] found 
that high oxygen supply favored cell mass formation at 
the expense of 2,3-BD production. Decreasing the oxygen 
supply would increase 2,3-BD yield, but it would decrease 
the overall conversion rate due to lower cell concentra-
tions [20, 21]. Therefore, it is necessary to establish a 
proper oxygen supply control strategy to ensure efficient 
2,3-BD production.
As it is easier to control dissolved oxygen concentration 
by changing agitation speed than by varying aeration rate, 
in this study, we investigated the characteristics of 2,3-BD 
fermentation by B. amyloliquefaciens GAR under differ-
ent oxygen supply methods by changing agitation speeds. 
Based on the analysis of two kinetic parameters including 
specific cell growth rate (μx) specific glycerol consump-
tion rate (μs) and specific 2,3-BD formation rate (μp) 
(Fig.  2), a three-stage agitation speed control strategy, 
aimed at achieving high concentration and high yield 2,3-
BD, was proposed. At the first 5  h, agitation speed was 
controlled at 350 rpm, subsequently agitation speed was 
raised to 400  rpm until 22  h, and then, agitation speed 
was reduced to 350  rpm (Fig.  3). Finally, the maximum 
concentration of 2,3-BD reached 42.6  g/L, which were 
9.85 % over the best results controlled by constant agita-
tion speeds. What’s more, titer of acetoin was reduced by 
61.5 %. The proposed three-stage agitation speed control 
strategy was therefore proved to be successful to enhance 
2,3-BD production. The idea developed in this paper 
could be applied to the other industrial biotechnological 
process to achieve high product concentration and high 
yield simultaneously.
Table 2 Metabolic flux distribution in B. amyloliquefaciens (unit: mol/mol substrate)
Strains Flux to
2,3‑BD Acetoin Lactate Succinate Acetate Biomass
B10‑127 0.695 0.174 0.027 0.036 0.022 0.048
GAR 0.862 0.061 0.012 0.015 0.013 0.043
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Some other parameter OTR [22], kLa [23], OUR [24] 
and RQ [25, 26] guided oxygen supply control strate-
gies were successfully applied in 2,3-BD fermentation 
and proved to be effective. However, the parameters 
of OTR, kLa, OUR and RQ are not easy to control, thus 
restricting the application of those strategies [20]. In this 
study, a simple oxygen supply method based on agita-
tion speed control was set up to realize efficient 2,3-BD 
fermentation.
Manipulating the carbon flux from acetoin 
to 2,3‑butanediol by using a two‑stage pH control strategy 
in fed‑batch fermentation
Firstly, fed-batch fermentation was performed under 
the combined feeding strategy (initial addition of beet 
molasses and later co-feeding with glycerol and molas-
ses) [11]. The representative time courses of fed-batch 
fermentation by B. amyloliquefaciens GAR are presented 
in Fig. 4a. The 2,3-BD reached 89.5 g/L within 90 h, how-
ever, it was accompanied by undesirably large production 
of acetoin (~20 g/L). However, as shown in Fig. 4a, since 
glycerol is rapidly synthesized within 80  h of fermenta-
tion, it was also found that time profiles of 2,3-BD pro-
duction could be divided into two stages. At the first 
24 h, pH values were below 7.0, and 2,3-BD was quickly 
accumulated, while acetoin was produced very slowly. 
After this point, the pH value gradually rise to about 8.0, 
which suppressed 2,3-BD formation, while enhanced ace-
toin accumulation. Since 2,3-BD is produced from pyru-
vate in a mixed acid fermentation process, the first pH 
decline may be related to rapid secretion of organic acids 
(such as lactate and acetate). Subsequent 2,3-BD synthe-
sis reverses the intracellular acidification and raises the 
pH [27].
Another major influence on 2,3-BD production is the 
pH [3]. Nakashimada et al. [27] reported that 2,3-BD syn-
thesis is induced under acid supplementation, which may 
suggest that 2,3-BD, as a neutral metabolite, counteracts 
too high acidification. According to Garg and Jain [12] 
alkaline conditions favour formation of organic acids, 
with a simultaneous decrease in the 2,3-BD yield. In con-
trary, organic acid synthesis is reduced (over tenfold) and 
diol synthesis is increased (3–7-fold) under acidic con-
ditions. Biebl et al. [8] observed that in Klebsiella sp., at 
neutral pH, it synthesizes acetic acid and ethanol, but 
below pH 6, 2,3-BD and ethanol are produced. However, 
the optimum pH for 2,3-BD production strongly depends 
on the microorganism and substrate used. Voloch et  al. 
[28] found the pH range from 5 to 6 was more beneficial 
to 2,3-BD production by K. oxytoca. For E. aerogenes, 
Converti et al. [21] and Perego et al. [29] all experimen-
tally determined a pH value of 6 as the optimum for the 
production of 2,3-BD. Stormer [30] found that in K. pneu-
moniae a pH above 6 causes a sharp decrease in the activ-
ity of α-acetolactate synthase (one of the key enzymes in 
the 2,3-BD pathway). Previously, the results also clearly 
showed that pH-dependent 2,3-BD production from 
glucose of B. amyloliquefaciens with the maximum pro-
duction was at initial pH 6.5, and in the initial stage of 
Fig. 2 Comparison of kinetic parameters in 2,3‑BD fermentation at 
different agitation speeds. (Batch fermentation was carried out at 
37 °C in a 5‑L bioreactor containing 2.5‑L initial medium (95 g/L co‑
substrate; molasses to crude glycerol ratio 1.5:8 (w/w)) at 37 °C, and 
airflow rate 0.66 vvm.)
Fig. 3 Time course of 2,3‑BD fermentation by B. amyloliquefaciens 
GAR using three‑stage agitation speed control strategy. (Batch 
fermentation was carried out at 37 °C in a 5‑L bioreactor containing 
2.5‑L initial medium (95 g/L co‑substrate; molasses to crude glycerol 
ratio 1.5:8 (w/w)) at 37 °C, airflow rate 0.66 vvm, and agitation speed: 
0–5 h, 350 rpm; 5–22 h, 400 rpm; 22–88 h, 350 rpm.)
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fermentation, it was good for 2,3-BD synthesis without 
external pH control [31]. Industrial-scale fermentation 
requires obeying safety regulations, therefore, an urgent 
need for class 1 microorganisms (safe) is pronounced. 
The Gram-positive bacterium B. amyloliquefaciens has 
been classified as GRAS (generally regarded as safe) by 
the US Food and Drug Administration [32]. Therefore, 
increasing 2,3-BD production by B. amyloliquefaciens is 
an economically valuable goal.
During the production of 2,3-BD from glycerol, acetoin 
is the precursor of 2,3-BD. So, it is very important that 
maintain the suitable conditions to steadily biosynthe-
size 2,3-BD from acetoin. Previously, it was found that 
the ACR, which catalyzes the interconversion between 
acetoin and 2,3-butanediol [31, 33]. We further deter-
mined the effects of pH on ACR activity. As shown in 
Fig.  5, ACR showed very different pH preferences of 
pH 6.5 for reduction and pH 8.5 for oxidation. In other 
words, this enzyme is critical for 2,3-BD biosynthesis, 
exhibits the highest activity at pH 6.5, whereas at pH 7.0, 
about 20 % of its activity is lost, and at pH 8.0, about half 
of its activity is lost. This pH property of ACR from other 
bacterium was also reported [34–36].
Basing on the above pH preference, a two-stage con-
trol strategy was proposed to improve 2,3-BD formation 
(Fig. 4b). At the first stage, the pH value was not under 
controlled for induction of 2,3-BD formation, and then 
when the pH value reached about 6.5, the pH control 
device began to work to maintained pH value at 6.5. As 
expected, through the strategy, the 2,3-BD production 
was up to 102.3 g/L (achieved at 88 h) with correspond-
ing productivity of 1.16 g/L h and a yield of 0.44 g/g sub-
strate, which were 14.8, 18.4 and 15.5 % higher than that 
under without pH control. Thus, the two-stage pH con-
trol strategy proposed in this work  is conducive to 2,3-
BD formation. To our knowledge, these are the highest 
reported levels of 2,3-BD fermentation from biodiesel-
derived glycerol.
Conclusion
Overexpressing the NADH/NAD+ regeneration system 
effectively improved 2,3-BD production and inhibited 
by-products accumulation. Medorate expression of ALsR 
made the 2,3-BD branch gain a competitive advantage 
over the end products of pyruvate-deriving pathways. The 
carbon flux from acetoin to 2,3-BD was manipulated by 
Fig. 4 Effect of pH control strategy on 2,3‑BD production by B. amyloliquefaciens GAR in fed‑batch fermentation. a Without pH control; b At the first 
16 h, the pH value was not under controlled, and after that point, pH was adjusted to 6.5.)
Fig. 5 Effect of pH on acetoin reductase activity
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using two-stage controlled pH and dissolved oxygen strat-
egies. Finally, a high titer (102.3 g/L), yield (0.44 g/g), and 
productivity (1.16 g/L/h) of 2,3-BD were achieved. To our 
knowledge, this is the highest reported 2,3-BD production 
using biodiesel-derived glycerol as a substrate, and this 
designed B. amyloliquefaciens should be an excellent can-
didate for producing 2,3-BD on an industrial scale.
Methods
Strains and plasmids
Strains, plasmids and primers used in this study are listed 
in Table  3. The parent strain was B. amyloliquefaciens 
B10-127, which has been deposited in the China Center 
for Type Culture Collection (CCTCC) under collec-
tion number CCTCC M 2012349. K. pneumoniae ATCC 
25955 was obtained from American Type Culture Collec-
tion. The recombinant derivatives of Escherichia coli/B. 
subtilis shuttle plasmid vector pMA5-HapII were hosted 
in E. coli JM109. This shuttle vector introduced the 
expression cassette for hyper-expression of dhaD, gldA, 
acr and alsR into B. amyloliquefaciens B10-127.
Culture conditions
B. amyloliquefaciens and E. coli were cultured in Luria-
Bertain (LB) medium. When necessary, ampicillin or 
kanamycin was added into the culture medium. For 
2,3-BD production, B. amyloliquefaciens was inocu-
lated into 10  mL LB medium added with 40  g/L glyc-
erol and cultivated overnight with agitation (180  rpm, 
rotary shaker) at 37  °C. After 12  h, 2.5  mL of the seed 
culture (OD600 =  5.0–6.0) was inoculated into fermen-
tation medium (crude glycerol (80  g/L), beet molasses 
(15 g/L) (Addition of beet molasses could enhance glyc-
erol assimilation [11] ), corn steep liquor (30 g/L), soy-
bean meal (20 g/L), ammonium citrate (5 g/L), K2HPO4 
(3 g/L), MgSO4·7H2O (0.3 g/L), FeSO4·7H2O (0.05 g/L), 
pH6.5). Waste glycerol comprised of 88  % (w/w) glyc-
erol, 6–9  % (w/w) water, 4–6  % (w/w) ash, 4  % (w/w) 
chlorides, and 0.2  % (w/w) methanol. The composi-
tion of beet molasses was 56.6 % (w/w) sucrose, 0.08 % 
(w/w) glucose, 23.8 % (w/w) water, 10 % (w/w) sulfated 
ash, 7.3  % (w/w) colloidal substances, and 2.1  % (w/w) 
nitrogen.
Table 3 Strains, plasmids and primers used in this study
Underlined nucleotides are the restriction enzyme sites
Bacterial strain, plasmid  
or primer names




  B10‑127 Host strain Lab stock
  DH B10‑127 with pMA5 ‑dhaD This study
  GL B10‑127 with pMA5‑gldA This study
  GA B10‑127 with pMA5‑acr‑HapII‑dhaD This study
  GAR B10‑127 with pMA5‑acr‑HapII‑dhaD‑PbdhA‑alsR This study
  K. pneumoniae ATCC 25955 Source of dhaD gene Lab stock
  E. coli JM109 Lab stock
 Plasmids
  pMA5‑HapII Expression vector (in E. coli, Apr; in B. amyloliquefaciens, Kanr) Lab stock
  pMA5‑acr pMA5‑HapII with acr (in E. coli, Apr; in B. amyloliquefaciens, Kanr) Lab stock
  pMA5‑PbahA‑alsR pMA5 containing PbahA‑alsR (in E. coli, Ap
r; in B. amyloliquefaciens, Kanr) Lab stock
  pMA5‑HpaII‑alsR pMA5 containing HpaII‑alsR (in E. coli, Apr; in B. amyloliquefaciens, Kanr) Lab stock
  pMA5‑gldA pMA5‑HapII with gldA (in E. coli, Apr; in B. amyloliquefaciens, Kanr) This study
  pMA5‑dhaD pMA5‑HapII with dhaD (in E. coli, Apr; in B. amyloliquefaciens, Kanr) This study
  pMA5‑acr‑HapII‑dhaD Apr, Kanr; pMA5‑HapII with acr and HapII‑dhaD (in E. coli, Apr;  
in B. amyloliquefaciens, Kanr)
This study
  pMA5‑acr‑HapII‑dhaD‑PbahA‑alsR Ap
r, Kanr; pMA5‑acr‑HapII‑dhaD with PbahA‑alsR (in E. coli, Ap
r;  
in B. amyloliquefaciens, Kanr)
This study
 Primers
  P1 5′‑CGGGATCCATGAAGCCTGAAGATATCG‑3′ BamHI
  P2 5′‑CGACGCGTCTATCCTGTCTTTTGCGC‑3′ MluI
  P3 5′‑CGACGCGTTTTTGAGTGATCTTCTC‑3′ MluI
  P4 5′‑CGGGATCCATGGATCGCATTATTCAATC‑3′ BamHI
  P5 5′‑CGACGCGTTTATTCCCATTCCTGCAGG‑3′ MluI
Page 9 of 11Yang et al. Microb Cell Fact  (2015) 14:122 
Batch fermentation was carried out at 37  °C in 250-
mL flasks or a 5-L bioreactor (BIOTECH-2002, Baoxing 
Biological Equipment Co., Shanghai, China) containing 
2.5-L initial medium (95  g/l co-substrate; molasses to 
crude glycerol ratio 1.5:8 (w/w)) at 37 °C and airflow rate 
0.66 vvm. The fed-batch (inoculated with 4  % v/v seed 
culture) was cultivated in a 5-L stirring bioreactor with 
a working volume of 2.5  l (15  g/l molasses). Glycerol at 
80 % (w/v), or a solution of 80 % glycerol, 15 % molasses, 
and 5 % H2O, was fed into the bioreactor to maintain the 
glycerol concentration between 20 and 50  g/l from 5 to 
88 h. Supplementation was ceased after 88 h to minimize 
the glycerol residue in the final broth [11].
Plasmids construction
The gene dhaD and gldA (encoding glycerol dehydroge-
nases) from K. pneumoniae ATCC 25955 were ampli-
fied by PCR technique using primers P1/P2 and P4/P5, 
respectively. The purified PCR products were separately 
double-digested by BamH I and Mlu I, and then ligated 
to the corresponding sites of the pMA5 plasmid. The 
recombinant plasmid pMA5-dhaD and pMA5-gldA were 
generated.
The dhaD gene, containing the HapII promoter from 
the pMA5-dhaD plasmid, was then PCR-amplified using 
primers P2 and P3. The amplified HapII-dhaD gene was 
inserted into the Mlu I site of the previously constructed 
plasmid pMA5-acr [15] to create the pMA5-acr-HapII-
dhaD plasmid. The PbdhA-alsR gene cut from the previ-
ously constructed plasmid pMA5-PbdhA-alsR [18] was 
inserted into the EcoR V and Hind III sites of the pMA5-
acr-HapII-dhaD plasmid to create the pMA5-acr-HapII-
dhaD-PbdhA-alsR plasmid. These constructed plasmids 
were isolated from E. coli JM109 and subsequently trans-
formed into B. amyloliquefaciens according to published 
method [37]. Furthermore, the stability of plasmids in B. 
amyloliquefaciens was also tested as described in our pre-
vious study [15].
Enzyme assays
The cell pellets collected by centrifugation were sus-
pended and washed with 0.1  M potassium phosphate 
buffer (pH7.0) at least for three times. For determining 
DhaD or GldA activity [14], the cell pellets were resus-
pended in binding buffer (20 mM potassium phosphate, 
500 mM NaCl, 20 mM imidazole, pH 7.4). For determin-
ing acetoin reductase (ACR) activity [38], the cell pellets 
were suspended in 0.1 M potassium phosphate buffer (pH 
6.5) containing 0.1 mM β-mercaptoethanol and 2 μg/mL 
phenylmethylsulfonyl fluoride. For acetolactate synthase 
(ALS) and acetolactate decarboxylase (ALDC) enzymes, 
the cell pellets were washed three times with wash buffer 
(0.2 mM NaH2PO4, 2.2 mM Na2HPO4, and 8.5 mM NaCl; 
pH 7.4) and then suspended in this buffer. Cells were dis-
rupted using a sonicator (SONICS, Newtown, CT) for 
20 min with chilling. The lysed cells were centrifuged at 
12,000 rpm for 25 min at 4 °C, and the supernatant was 
used for enzyme assays. The ALS and ALDC assays were 
performed according to published procedures [39].
Analytical methods
The cell mass concentration was determined from the 
OD600 in a UV–visible spectroscopy system (UV-2000, 
UNICO, America). The dry cell weight (DCW) was cal-
culated from the optical density using a calibration curve 
for the strain. The composition of the fermentation broth 
(glycerol, 2,3-BD, acetoin, acetate, lactate and succinate) 
was determined by high-performance liquid chromatog-
raphy (HPLC) [31]. The intracellular NAD+ and NADH 
concentrations were measured by procedures described 
previously [40]. All assays were performed by triplicate 
cultures.
Kinetic parameters calculation
The specific cell growth rate (μX, h−1), specific substrate 
consumption rate (μS, h−1) and specific 2,3-BD forma-
tion rate (μP, h−1) were estimated from experimental 
or fitted data of cell growth (X, g/L), residual substrate 
concentration (S, g/l), and 2,3-BD production (P, g/L) by 
Eqs.  (1)–(3), respectively. The fitted data were obtained 
by interposing between experimental data of cell growth, 
residual substrate concentration or 2,3-BD production at 
definite time (dt = 0.1 h) with the approximation method 
of cubic spline interpolation in Origin software (Version 
8.0, OriginLab Corp., Northampton, MA, USA) [20].
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